Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01516307 |
|
Recruitment Status
:
Active, not recruiting
First Posted
: January 24, 2012
Last Update Posted
: March 3, 2017
|
Sponsor:
OBI Pharma, Inc
Information provided by (Responsible Party):
OBI Pharma, Inc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | August 2016 |
| Estimated Study Completion Date : | August 2019 |
| Certification/Extension First Submitted : | March 2, 2017 |